Amerant faces margin pressure from high deposit costs and real estate exposure, despite strategic risk reduction and asset quality improvements. Potential upside exists, with fair value estimated at ...
In an interview with Swissinfo, Weleda CEO says talks about the quiet revolution she initiated at the Swiss cosmetics and healthcare company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results